| Barchart Demo Center |
$47.01
+0.51 (+1.10%)
as of May 17, 2024
as of May 17, 2024
| Last | 47.01 |
|---|---|
| Change | +0.51 (+1.10%) |
| Open | 46.72 |
| Prev. Close | 46.50 |
| Today's Range |
45.42
47.21
|
| 52wk Range |
12.62
50.50
|
| Volume | 649,336 |
| Avg Volume | 1,325,662 |
| Sector | SIC-2836 Biological Products, (No Disgnostic Substanc |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| TWST |
 +1.10% |
 +23.74% |
+262.17% |
| DJIA |
+0.34% |
+3.13% |
+19.70% |
| S&P 500 |
+0.12% |
+2.83% |
+27.52% |
Key Statistics
| Annual EPS | -3.36 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 2,802,420 |
| Weighted Alpha | +143.73 |
| Standard Deviation | +0.17 |
| Profit Margin | -69.24% |
| Beta | 1.64 |
Growth Rates
| YTD | +27.54% | |||
| 1-Year | +256.87% | |||
| 3-Year | -51.26% | |||
| 5-Year | +78.91% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
Twist Bioscience Launches Multiplexed Gene Fragments
Business Wire - Mon May 13, 07:00AM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (full story)
TWST: 47.01 (+0.51)
Twist Bioscience Corporation Announces Inducement
Business Wire - Wed May 08, 07:00AM CDT
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synt(full story)
TWST: 47.01 (+0.51)
Twist Bioscience: Fiscal Q2 Earnings Snapshot
AP - Thu May 02, 03:33PM CDT
Twist Bioscience: Fiscal Q2 Earnings Snapshot(full story)
TWST: 47.01 (+0.51)
Twist Bioscience Reports Fiscal Second Quarter 2024
Business Wire - Thu May 02, 03:05PM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the (full story)
TWST: 47.01 (+0.51)
Twist Bioscience to Report Fiscal 2024 Second Quarter
Business Wire - Thu Apr 18, 07:00AM CDT
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the f(full story)
TWST: 47.01 (+0.51)